A paraneoplastic syndrome exacerbated by checkpoint inhibition therapy

In this report, we present a case of polymyalgia rheumatica presenting as a paraneoplastic syndrome that was exacerbated during therapy with immune checkpoint inhibitors for recurrent melanoma.PMID:33456171 | PMC:PMC7785140 | DOI:10.1080/08998280.2020.1824962

Source: Baylor University Medical Center Proceedings - January 18, 2021 Category: Universities & Medical Training Authors: Heather Villarreal Kathryn H Dao Source Type: research